From Raleigh, North Carolina, USA:
Why does Cygnus describe their perhaps soon-to-be-FDA-approved GlucoWatch as something available to "adults 18 and over" with diabetes? Why this seemingly arbitrary stipulation?
The test data submitted to the FDA for review most likely only included results from people over the age of 18. As a result, the product would be approved only for people over the age of 18. That does not mean that the product cannot be prescribed for others, however, as drugs and similar FDA-reviewed products are sometimes prescribed by physicians to be used in other circumstances ("off-label").
Original posting 31 Aug 1999
Posted to Research: Monitoring
|Return to the Top of This Page|
Last Updated: (none)
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.